Ellen L. Goode

Assessing genotype−phenotype correlations in colorectal cancer with deep learning: a multicentre cohort study

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

GWAS meta-analysis identifies five susceptibility loci for endometrial cancer

Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer

Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Risk Factors for Ovarian Cancer by <i>BRCA</i> Status: A Collaborative Case-Only Analysis

Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature

Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis

Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas

Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors

Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 ⁺ TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

Prognostic gene expression signature for high-grade serous ovarian cancer

Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers

Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

<i>BRCA1</i>Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis